A
Price
$172.92
Change
-$2.63 (-1.50%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
49.4B
45 days until earnings call
Intraday BUY SELL Signals
WRBY
Price
$23.39
Change
-$1.20 (-4.88%)
Updated
Oct 16, 04:59 PM (EDT)
Capitalization
3.05B
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

A vs WRBY

A vs WRBY Comparison Chart in %
View a ticker or compare two or three
VS
A vs. WRBY commentary
Oct 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is A is a Hold and WRBY is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for A with price predictions
Oct 15, 2026

Momentum Indicator for A turns positive, indicating new upward trend

A saw its Momentum Indicator move above the 0 level on October 14, 2026. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 86 similar instances where the indicator turned positive. In 57 of the 86 cases, the stock moved higher in the following days. The odds of a move higher are at 66%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +2.30% 3-day Advance, the price is estimated to grow further. Considering data from situations where A advanced for three days, in 186 of 301 cases, the price rose further within the following month. The odds of a continued upward trend are 62%.

The Aroon Indicator entered an Uptrend today. In 137 of 209 cases where A Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 66%.

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The Moving Average Convergence Divergence Histogram (MACD) for A turned negative on October 07, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In 29 of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at 64%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where A declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

A broke above its upper Bollinger Band on September 24, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 7 (best 1 - 100 worst), indicating outstanding price growth. A’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.707) is normal, around the industry mean (72.578). P/E Ratio (34.558) is within average values for comparable stocks, (146.993). Projected Growth (PEG Ratio) (1.447) is also within normal values, averaging (3.473). A has a moderately high Dividend Yield (0.006) as compared to the industry average of (0.001). P/S Ratio (5.910) is also within normal values, averaging (9.775).

The Tickeron PE Growth Rating for this company is 27 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 46 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 75 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 90 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. A’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

A.I.Advisor
a Summary for WRBY with price predictions
Oct 15, 2026

WRBY in downward trend: price dove below 50-day moving average on October 14, 2026

WRBY moved below its 50-day moving average on October 14, 2026 date and that indicates a change from an upward trend to a downward trend. In 42 of 48 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 88%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on WRBY as a result. In 56 of 74 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 76%.

The Moving Average Convergence Divergence Histogram (MACD) for WRBY turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 41 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 80%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where WRBY declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 78%.

WRBY broke above its upper Bollinger Band on September 29, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for WRBY entered a downward trend on September 28, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The 10-day moving average for WRBY crossed bullishly above the 50-day moving average on October 02, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 16 of 18 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.

Following a +4.82% 3-day Advance, the price is estimated to grow further. Considering data from situations where WRBY advanced for three days, in 227 of 275 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 56 (best 1 - 100 worst), indicating fairly steady price growth. WRBY’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 87 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.776) is normal, around the industry mean (5.011). P/E Ratio (411.000) is within average values for comparable stocks, (163.451). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.456). Dividend Yield (0.000) settles around the average of (0.005) among similar stocks. P/S Ratio (3.231) is also within normal values, averaging (56.074).

The Tickeron SMR rating for this company is 88 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is 99 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. WRBY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
A: Fundamental Ratings
A
OUTLOOK RATING
1..100
38
VALUATION
overvalued / fair valued / undervalued
1..100
11
Undervalued
PROFIT vs RISK RATING
1..100
90
SMR RATING
1..100
46
PRICE GROWTH RATING
1..100
7
P/E GROWTH RATING
1..100
27
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AWRBY
RSI
ODDS (%)
Bearish Trend 2 days ago
72%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bullish Trend 2 days ago
78%
Momentum
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
76%
MACD
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
80%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
64%
Bearish Trend 2 days ago
77%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
Bullish Trend 2 days ago
62%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 9 days ago
64%
Bearish Trend 2 days ago
78%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
60%
Bearish Trend 2 days ago
75%
Aroon
ODDS (%)
Bullish Trend 2 days ago
66%
Bearish Trend 2 days ago
78%
COMPARISON
Comparison
Oct 16, 2026
Stock price -- (A: $175.55 vs. WRBY: $24.59)
Brand notoriety: A and WRBY are both not notable
A represents the Medical Specialties, while WRBY is part of the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: A: 83% vs. WRBY: 142%
Market capitalization -- A: $49.4B vs. WRBY: $3.05B
A [@Medical Specialties] is valued at $49.4B. WRBY’s [@Pharmaceuticals: Other] market capitalization is $3.05B. The market cap for tickers in the [@Medical Specialties] industry ranges from $27 to $4.39T. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $126 to $146.54B. The average market capitalization across the [@Medical Specialties] industry is $20.78B. The average market capitalization across the [@Pharmaceuticals: Other] industry is $8.89B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

A’s FA Score shows that 3 FA rating(s) are green while WRBY’s FA Score has 0 green FA rating(s).

  • A’s FA Score: 3 green, 2 red.
  • WRBY’s FA Score: 0 green, 5 red.
According to our system of comparison, A is a better buy in the long-term than WRBY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

A’s TA Score shows that 3 TA indicator(s) are bullish while WRBY’s TA Score has 3 bullish TA indicator(s).

  • A’s TA Score: 3 bullish, 5 bearish.
  • WRBY’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, A is a better buy in the short-term than WRBY.

Price Growth

A (@Medical Specialties) experienced а +4.39% price change this week, while WRBY (@Pharmaceuticals: Other) price change was -1.44% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -6.18%. For the same industry, the average monthly price growth was -4.82%, and the average quarterly price growth was +31.71%.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -1.42%. For the same industry, the average monthly price growth was -3.61%, and the average quarterly price growth was +3.35%.

Reported Earning Dates

A is expected to report earnings on Nov 30, 2026.

WRBY is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical Specialties (-6.18% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

@Pharmaceuticals: Other (-1.42% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

View a ticker or compare two or three
A
Daily Signal:
Gain/Loss:
WRBY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
QQLV25.350.24
+0.94%
Invesco QQQ Low Volatility ETF (QQLV)
GTPE60.340.38
+0.64%
Goldman Sachs MSCI World Private Equity Return Tracker ETF (GTPE)
INCE67.210.34
+0.51%
Franklin Income Equity Focus ETF (INCE)
EPS80.890.27
+0.33%
WisdomTree U.S. LargeCap Fund (EPS)
DMX48.950.11
+0.23%
DoubleLine Multi-Sector Income ETF

A and

Correlation & Price change

A.I.dvisor indicates that over the last year, A has been closely correlated with TMO. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if A jumps, then TMO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To A
1D Price
Change %
A100%
+0.89%
TMO - A
72%
Closely correlated
+3.46%
BRKR - A
72%
Closely correlated
+1.69%
MTD - A
68%
Closely correlated
+1.85%
RGEN - A
67%
Closely correlated
+3.35%
WAT - A
64%
Loosely correlated
+1.73%
More

WRBY and

Correlation & Price change

A.I.dvisor indicates that over the last year, WRBY has been loosely correlated with TWST. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if WRBY jumps, then TWST could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To WRBY
1D Price
Change %
WRBY100%
-1.32%
TWST - WRBY
45%
Loosely correlated
-2.48%
GKOS - WRBY
43%
Loosely correlated
-1.36%
MTD - WRBY
41%
Loosely correlated
+1.85%
GMED - WRBY
40%
Loosely correlated
+3.32%
A - WRBY
40%
Loosely correlated
+0.89%
More